ArticleBioscience reports2019

Pioglitazone protects blood vessels through inhibition of the apelin signaling pathway by promoting KLF4 expression in rat models of T2DM.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.